Related references
Note: Only part of the references are listed.FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Dhanya Kalathil et al.
FRONTIERS IN ONCOLOGY (2021)
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman et al.
ENDOCRINE-RELATED CANCER (2019)
Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Nicole M. Kettner et al.
CLINICAL CANCER RESEARCH (2019)
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
Nicole Cortes et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (diva) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC).
Amy Jo Chien et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
ANTITUMOR ACTIVITY OF PEMBROLIZUMAB PLUS DINACICLIB IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA: THE PHASE 1B KEYNOTE-155 STUDY
G. Gregory et al.
HEMATOLOGICAL ONCOLOGY (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
Ramesh Elango et al.
SCIENTIFIC REPORTS (2019)
Everolimus Reverses Palbociclib Resistance in ER plus Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
Lin Chen et al.
MEDICAL SCIENCE MONITOR (2019)
A Nestin-Cyclin-Dependent Kinase 5-Dynamin-Related Protein 1 Axis Regulates Neural Stem/Progenitor Cell Stemness via a Metabolic Shift
Jiancheng Wang et al.
STEM CELLS (2018)
Foxm1 controls a pro-stemness microRNA network in neural stem cells
Zein Mersini Besharat et al.
SCIENTIFIC REPORTS (2018)
CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Dinoop Ravindran Menon et al.
CANCER RESEARCH (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
Alexander Ring et al.
CANCERS (2018)
Epidemiology, Incidence and Mortality of Breast Cancer in Asia
Mahshid Ghoncheh et al.
Asian Pacific Journal of Cancer Prevention (2017)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells
Dejie Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Roles of FoxM1 in cell regulation and breast cancer targeting therapy
Xin Song et al.
MEDICAL ONCOLOGY (2017)
G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells
Lijun Liu et al.
NATURE CELL BIOLOGY (2017)
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells
N. Yang et al.
ONCOGENE (2017)
Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia
Paolo Ghia et al.
BLOOD (2017)
Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells
Athanasia Pavlopoulou et al.
CANCER LETTERS (2016)
The positive transcriptional elongation factor (P-TEFb) is required for neural crest specification
Victoria L. Hatch et al.
DEVELOPMENTAL BIOLOGY (2016)
RBPJ maintains brain tumor-initiating cells through CDK9-mediated transcriptional elongation
Qi Xie et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Inhibition of cyclin dependent kinase 9 by dinaciclib suppresses cyclin B1 expression and tumor growth in triple negative breast cancer
Sandeep Rajput et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
Forkhead Box M1 Is Essential for Nuclear Localization of Glioma-associated Oncogene Homolog 1 in Glioblastoma Multiforme Cells by Promoting Importin-7 Expression
Jianfei Xue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation
Li-Hua Sun et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
Jian Kang et al.
BMC CANCER (2014)
Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24-/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells
Mateusz Opyrchal et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
CDK1 plays an important role in the maintenance of pluripotency and genomic stability in human pluripotent stem cells
I. Neganova et al.
CELL DEATH & DISEASE (2014)
Cyclin D1/Cdk4 increases the transcriptional activity of FOXM1c without phosphorylating FOXM1c
Inken Wierstra
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Cdks, cyclins and CKIs: roles beyond cell cycle regulation
Shuhui Lim et al.
DEVELOPMENT (2013)
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
F. Andre et al.
ANNALS OF ONCOLOGY (2012)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
A Distinct Role for Pin1 in the Induction and Maintenance of Pluripotency
Mayuko Nishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates
Randy Suryadinata et al.
BIOSCIENCE REPORTS (2010)
Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells
Christian Lange et al.
CELL CYCLE (2010)
Phosphorylation stabilizes Nanog by promoting its interaction with Pin1
Matteo Moretto-Zita et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Yvonne Tay et al.
NATURE (2008)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
